Follow
Bhavana Bhatnagar
Bhavana Bhatnagar
West Virginia Cancer Institute
Verified email at hsc.wvu.edu
Title
Cited by
Cited by
Year
Chronic myeloid leukemia, version 2.2021, NCCN clinical practice guidelines in oncology
MW Deininger, NP Shah, JK Altman, E Berman, R Bhatia, B Bhatnagar, ...
Journal of the National Comprehensive Cancer Network 18 (10), 1385-1415, 2020
2692020
Chronic myeloid leukemia, version 1.2019, NCCN clinical practice guidelines in oncology
JP Radich, M Deininger, CN Abboud, JK Altman, E Berman, R Bhatia, ...
Journal of the National Comprehensive Cancer Network 16 (9), 1108-1135, 2018
2642018
Chemotherapy dose reduction due to chemotherapy induced peripheral neuropathy in breast cancer patients receiving chemotherapy in the neoadjuvant or adjuvant settings: a single …
B Bhatnagar, S Gilmore, O Goloubeva, C Pelser, M Medeiros, S Chumsri, ...
Springerplus 3, 1-6, 2014
1522014
Effectiveness of integrated palliative and oncology care for patients with acute myeloid leukemia: a randomized clinical trial
A El-Jawahri, TW LeBlanc, A Kavanaugh, JA Webb, VA Jackson, ...
JAMA oncology 7 (2), 238-245, 2021
1472021
Consolidation therapy with blinatumomab improves overall survival in newly diagnosed adult patients with B-lineage acute lymphoblastic leukemia in measurable residual disease …
MR Litzow, Z Sun, E Paietta, RJ Mattison, HM Lazarus, JM Rowe, ...
Blood 140 (Supplement 2), LBA-1-LBA-1, 2022
1002022
XPO1 inhibition using selinexor synergizes with chemotherapy in acute myeloid leukemia by targeting DNA repair and restoring topoisomerase IIα to the nucleus
P Ranganathan, T Kashyap, X Yu, X Meng, TH Lai, B McNeil, ...
Clinical Cancer Research 22 (24), 6142-6152, 2016
942016
NCCN guidelines insights: chronic myeloid leukemia, version 1.2017
A Pallera, JK Altman, E Berman, CN Abboud, B Bhatnagar, P Curtin, ...
Journal of the National Comprehensive Cancer Network 14 (12), 1505-1512, 2016
762016
Clinical activity of axicabtagene ciloleucel in adult patients with Richter syndrome
AS Kittai, DA Bond, B William, A Saad, S Penza, Y Efebera, K Larkin, ...
Blood Advances 4 (19), 4648-4652, 2020
692020
Persistence of DNMT3A R882 mutations during remission does not adversely affect outcomes of patients with acute myeloid leukaemia
B Bhatnagar, AK Eisfeld, D Nicolet, K Mrózek, JS Blachly, S Orwick, ...
British journal of haematology 175 (2), 226-236, 2016
692016
Decitabine priming enhances the antileukemic effects of exportin 1 (XPO1) selective inhibitor selinexor in acute myeloid leukemia
P Ranganathan, X Yu, R Santhanam, J Hofstetter, A Walker, K Walsh, ...
Blood, The Journal of the American Society of Hematology 125 (17), 2689-2692, 2015
682015
Poor survival and differential impact of genetic features of black patients with acute myeloid leukemia
B Bhatnagar, J Kohlschmidt, K Mrózek, Q Zhao, JL Fisher, D Nicolet, ...
Cancer discovery 11 (3), 626-637, 2021
662021
AML with myelodysplasia-related changes: development, challenges, and treatment advances
KL Koenig, KD Sahasrabudhe, AM Sigmund, B Bhatnagar
Genes 11 (8), 845, 2020
662020
NCCN guidelines insights: acute lymphoblastic leukemia, Version 1.2019: featured updates to the NCCN guidelines
PA Brown, M Wieduwilt, A Logan, DJ DeAngelo, ES Wang, A Fathi, ...
Journal of the National Comprehensive Cancer Network 17 (5), 414-423, 2019
632019
Ten-day decitabine as initial therapy for newly diagnosed patients with acute myeloid leukemia unfit for intensive chemotherapy
B Bhatnagar, VH Duong, TS Gourdin, ML Tidwell, C Chen, Y Ning, ...
Leukemia & lymphoma 55 (7), 1533-1537, 2014
622014
Loncastuximab tesirine, an anti-CD19 antibody-drug conjugate, in relapsed/refractory B-cell acute lymphoblastic leukemia
N Jain, W Stock, A Zeidan, E Atallah, J McCloskey, L Heffner, B Tomlinson, ...
Blood advances 4 (3), 449-457, 2020
562020
Complete responses in relapsed/refractory acute myeloid leukemia (AML) patients on a weekly dosing schedule of XmAb14045, a CD123 x CD3 T cell-engaging bispecific antibody …
F Ravandi, A Bashey, JM Foran, W Stock, R Mawad, W Blum, MW Saville, ...
Blood 132, 763, 2018
552018
Midostaurin, bortezomib and MEC in relapsed/refractory acute myeloid leukemia
AR Walker, H Wang, K Walsh, B Bhatnagar, S Vasu, R Garzon, ...
Leukemia & lymphoma 57 (9), 2100-2108, 2016
502016
Selinexor in combination with decitabine in patients with acute myeloid leukemia: results from a phase 1 study
B Bhatnagar, Q Zhao, AS Mims, S Vasu, GK Behbehani, K Larkin, ...
Leukemia & lymphoma 61 (2), 387-396, 2020
462020
Entospletinib in combination with induction chemotherapy in previously untreated acute myeloid leukemia: response and predictive significance of HOXA9 and MEIS1 expression
AR Walker, JC Byrd, JS Blachly, B Bhatnagar, AS Mims, S Orwick, TL Lin, ...
Clinical Cancer Research 26 (22), 5852-5859, 2020
402020
Blinatumomab for MRD-negative acute lymphoblastic leukemia in adults
MR Litzow, Z Sun, RJ Mattison, EM Paietta, KG Roberts, Y Zhang, ...
New England Journal of Medicine 391 (4), 320-333, 2024
372024
The system can't perform the operation now. Try again later.
Articles 1–20